A brain implant to control brain functions and treat neurological disorders: Elon Musk’s latest gamble



[ad_1]

First the bet ofelectric car with the creation of Tesla, then the conquest of space with the birth of Spacex. But the last challenge of Elon musk goes further: the goal is to enter brain human. That’s why in 2016 the visionary entrepreneur from Silicon Valley wanted to found Neuralink, start-up specialized in neurotechnology and artificial intelligence. A company whose main objective is develop implantable neural interfaces, devices that can explore and study a human brain in a whole new way, with huge potential especially in the medical and scientific fields. The final step could be the cure for many unrest neurological, from memory loss to depression, according to Musk’s presentation.

The ‘brain-machine’ developed so far has the appearance of a chip as big as a coin: is wireless and is being tested on pigs. It is no coincidence that Musk presented the results achieved with what he called a ‘demo of the three piglets“. A live demonstration of the operation of the device created so far that, once implanted, allows to observe the animal brain connections. In short, the brain as no one has seen it until now. The demonstration turned out to be a success, with brain signals from Gertrude (so Musk called a pig that had been implanted with the chip for two months) visible in real time.

The bet now is to be able to test this technology on a human by the end of 2020. Musk explained how Neuralink in particular is developing much smaller and more flexible devices than filaments up to ten times thinner than hair. “It will be like having a FitBit in the brain, ”said the Tesla and SpaceX guru, explaining that potential applications are a supervision brain functions so far impossible, but also the treatment of brain injuries and trauma. However, the greatest ambition is to one day make a real one possible. symbiosis between human intelligence and artificial intelligence. The prototypes of these technological devices have already been tested in at least 19 different animals with an experiment success rate of 87%.

Support ilfattoquotidiano.it: I never eat right now
we need you.

In these weeks of pandemic, journalists, if we do our job conscientiously, we do a public service. Also for this reason, every day here at ilfattoquotidiano.it we are proud to offer hundreds of new content for free to all citizens: news, exclusive insights, expert interviews, surveys, videos and much more. All this work, however, comes at great financial cost. Advertising, at a time when the economy is stagnant, offers limited income. Not in line with the access boom. That is why I ask those who read these lines to support us. Give us a minimum contribution, equal to the price of a cappuccino per week, which is essential for our work.
Become a support user by clicking here.

Thank you
Peter gomez

But now we are the ones who need you. Because our work has a cost. We are proud to be able to offer hundreds of new content to all citizens for free every day. But advertising, at a time when the economy is stagnant, offers limited revenue. Not in line with the boom in access to ilfattoquotidiano.it. That is why I ask you to support us, with a minimum contribution, equal to the price of one cappuccino per week. A small but fundamental sum for our work. Give us a hand!
Become a support user!

With gratitude
Peter gomez

ilFattoquotidiano.it

Support now

Available payments

Previous article

Coronavirus and school, children and adolescents towards the classrooms. Studies: “Covid less frequent in children”, “Less susceptible under 20 years”

following

[ad_2]